The global blood pressure monitoring devices market size was valued at USD 1.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.2% from 2021 to 2028. Increasing incidences of hypertension due to changing lifestyles are contributing to the growth of the market over the forecast period.
Advancements such as mobile-based BP monitoring systems and digital sphygmomanometer are anticipated to drive the demand. Improvement in devices for measuring blood pressure is positively impacting the market growth. Wearable and portable devices and mobiles are gaining popularity owing to the associated benefits such as the wireless transmission of patient information and easy handling. New technologies such as mHealth, which supports treatment and medication compliances for patients in chronic disease management, are expected to fuel market growth. It helps in tracking the patient’s health information, medication schedule, and follow up for the treatment. These associated advantages are expected to propel the market growth.
Key Player Mentioned:
- Koninklijke Philips N.V.
- General Electric Company
- A & D Company, Limited
- Welch Allyn
- SunTech Medical, Inc.
- American Diagnostic Corporation
- Withings
- Briggs Healthcare
To identify the key drivers and the competitors’ insights, Request a Sample @:
New product launches, along with technological advancements, are further expected to fuel the demand. For instance, in May 2018, Hill-Rom launched Welch Allyn home blood pressure monitors and digital scale products in the U.S. In addition, a rising preference for home healthcare, coupled with awareness about the importance of early diagnosis of hypertension and cardiac diseases, is expected to boost the market growth.
Product Segment Analysis:
- Sphygmomanometer/Aneroid BP Monitors
- Automated/Digital Blood Pressure Monitors
- Ambulatory Blood Pressure Monitors
- Transducers
- Instruments and Accessories
Application Segment Analysis:
- Hospitals
- Ambulatory Surgical Centers & Clinics
- Home Healthcare
Access Press Release @ https://www.grandviewresearch.com/press-release/global-blood-pressure-monitoring-devices-market
Regional Segment Analysis:
North America, Europe, Asia Pacific, Latin America, and Mideast and Africa.
Blood pressure cuffs are expected to grow at a significant rate over the forecast period due to the increasing usage of blood pressure monitors, which is attributed to the growing incidence of high blood pressure. These cuffs are available in different sizes according to the patient type. Two types of cuffs: disposable and reusable are available in the market. Amongst this, the disposable segment is anticipated to expand at a high CAGR due to the rising adoption of eco-friendly products and increasing concerns about hospital-based cross-contamination events. For instance, in July 2020, Vancouver Coastal Health—a regional health authority—replaced its reusable blood pressure cuffs with disposable ones to prevent cross-contamination and limit the spread of COVID-19, thereby increasing the demand for disposable blood pressure cuffs by its affiliated members.
In 2020, the demand for in-home health management witnessed significant growth due to the spread of COVID-19. For instance, according to a report published by Omron, its home healthcare business segment witnessed an increased demand for thermometers and blood pressure monitors in Europe, Japan, and Central and South America during the pandemic.
KEY aspects covered in the report include:
- The market size and industry growth rate of the global and regional market across various segments
- The region or the sub-segment that is expected to drive the Blood Pressure Monitoring Devices market in the forecast period 2021-2028
- Key companies operating in the global Blood Pressure Monitoring Devices market and their market share
- The Factors that are estimated to drive the Blood Pressure Monitoring Devices Market growth
- Key opportunities in the Blood Pressure Monitoring Devices market
- Key technological advancements and market trends that shape the market
The study objectives of this report are:
- To research global status, future forecasts, growth opportunities, key markets and key players.
- To present the market development in us, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and methods.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Autoinjectors are easy-to-handle and cost-effective medical devices that can be used by patients, caregivers, and even untrained personnel to deliver a dose of a particular drug.
Autoinjectors are used by patients to manage autoimmune diseases and chronic diseases.
They are used for a wide range of indications such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724According to the new market research report “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023", published by MarketsandMarkets™, The global Autoinjectors Market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023).The key factors driving the growth of this market include the growing prevalence of targeted therapies such as rheumatoid arthritis and multiple sclerosis, rising incidence of anaphylaxis, and increasing number of regulatory approvals.Use of autoinjectors in the treatment of rheumatoid arthritis drives the global autoinjectors marketRheumatoid arthritis (RA) is a chronic, systemic, inflammatory autoimmune disease that affects connective tissues.
It causes joints to swell and can result in pain, stiffness, and progressive loss of function.
According to the CDC, an estimated 43.7 million adults (22.7% of the total population) in the US annually are affected by some form of arthritis, RA, gout, lupus, or fibromyalgia.What Drives the Market?1.
Growing prevalence of targeted therapies2.
